相关实验视频

Updated: Jun 17, 2025

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

Published on: February 9, 2016

在55只患有心肺疾病的猫群中对西尔德纳菲尔的回顾性研究 (2009-2021)

Jasmine Huynh¹, Samantha Dolan¹, Emily T Karlin¹

¹Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA 01536, USA.

Animals : an open access journal from MDPI

|August 10, 2024

概括

对于猫的心肺疾病,西尔德纳菲尔的使用通常看起来是安全的,几乎没有副作用. 需要进一步的研究来证实它在改善猫类生活质量和生存时间方面的有效性.

科学领域:

兽医医学兽医医学兽医医学
药理学药理学是指药理学的学科.

背景情况:

西尔德纳菲尔被确立用于人类和狗的心肺疾病.
关于锡尔德纳菲尔在猫科动物医学中的使用和疗效的数据有限.

研究的目的:

审查西尔代纳菲尔在猫的临床使用和结果.
评估西尔代纳菲尔在猫患者中的安全性和耐受性.

主要方法:

医疗记录和药房数据库的回顾性审查 (2009-2021年).
纳入标准:接受西尔代纳菲尔≥24小时的猫.
收集关于疾病类型,副作用和治疗持续时间的数据.

主要成果:

包括55只猫:43只患有心脏病,12只患有呼吸系统疾病.
两只猫出现了可能的副作用:全身低血压 (n=1) 和多滴水症 (n=1).
由于副作用或缺乏疗效,西尔德纳菲尔在5只猫中断使用;没有观察到肺胀恶化.

结论:

对于心肺病的猫,西尔德纳菲尔的使用通常被很好地容忍.
需要进一步的研究来评估西尔德纳菲尔对猫类生命质量和生存的影响.

关键词:

心肌病性心脏病 - 心肌病性心脏病心肺肺部疾病是什么心肺疾病遗传性心脏病是一种先天性心脏病.充血性心力衰竭是一种肺高血压是一种肺高血压.这种药物是西尔代纳菲尔.

更多相关视频

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...